Quarterly report pursuant to Section 13 or 15(d)

Shareholders Equity and Capital Stock (Details 5)

v3.24.3
Shareholders Equity and Capital Stock (Details 5)
 9 Months Ended
Sep. 30, 2024
$ / shares
shares
Outstanding warrants  
Outstanding Beginning Balance, Warrants 55,417,500
Number of warrants, Exercised (16,376,500)
Outstanding Ending Balance, Warrants 39,041,000
Number of shares to be issued upon exercise  
Outstanding Beginning Balance, Number of shares to be issued upon exercise 27,708,750
Number of shares to be issued upon exercise, Exercised (8,188,250)
Outstanding Ending Balance, Number of shares to be issued upon exercise 19,520,500
Per share exercise price  
Per share exercise price, Outstanding Beginning | $ / shares $ 1.46
Per share exercise price, Exercised | $ / shares 1.35
Per share exercise price, Outstanding Ending | $ / shares $ 1.50